Cheney: Células Madre y XMRV en el SFC

[EndSFC]

Este es un extracto filtrado en el foro de PR, que leí hace unos meses, que en realidad hay que pagar bastante para leerlo. Como está filtrado por alguien y se puede encontrar en un foro público, mientras no lo quiten, aquí lo dejo:

(Merece mucho la pena traducirlo, pero no tengo fuerzas)

http://forums.aboutmecfs.org/showthread ... post143533" onclick="window.open(this.href);return false;

Latest from cheney:
September 18th, 2010, published in Stem Cell Therapy, Subscribers Categories

New stem cell treatments in Panama have rapidly slowed and perhaps justifiably so after the increasing realization that several trips and perhaps annual trips may be necessary, even for the best responders, to maintain any peak benefit. I think this is due to the high incidence of XMRV re-activation under either stressors or immune activation such as an infection (flu season) or allergy season as was the case with my step-son (he relapsed with allergy season). He did respond very well to the second transfusion and is back in school so it was worth it to us but we can afford multiple trips if the benefit is so dramatic. He also failed to do anything other than the stem cells after the first trip because he felt cured after this initial visit. The cost of having him miss school is even more expensive over time so it even made economic sense. He is now on the typical regime all my patients are on including Artesunate and CSF’s/HPE. When we get to a better anti-viral strategy (ie Artesunate titration, GcMAF, Transfer Factor or Peptide-T) using the GFP-LNCaP quantitative assay, we can optimize it and my hope is that this will prolong the benefit as well as enhance the benefit of stem cells, at least for those under 60. I am not as sure about stem cells for those over sixty and not altogether sure why this is so but significant reservations also apply to those over sixty receiving organ transplants as there appears to be a rapidly declining benefit curve with age, especially over 60, for almost any therapy. This was also seen in the U. of Colorado stem cell treatment of Parkinsons 15 years ago. Those over sixty responded very little to stem cells in contract to those under 60. It may simply be harder to make an over 60 year-old twenty again but much easier to make a twenty year old with CFS feel twenty again. There is the possibility though that anti-viral strategies may work well in those over sixty as well. We will see. Right now, I can only strongly recommend stem cells for those under 35 and only under the proviso that they may need additional trips over time to maintain benefit. Those over 40 but under 60 will likely see less of a response to stem cells compared to those under 35 and may also need repeated visits to maintain their peak benefit. Those over 60 should probably wait until we can optimize this very promising therapy but it is their call. All stem cell patients should use our current anti-viral recommendations as well as CSF support which does seem to improve the level of response to stem cells and helps prevent early regression.

[elipoarch]

Yo diría que esto ya lo teníamos... lo comprobaré cuando pueda.

[EndSFC]

no, no está...era privado, y yo lo expliqué por encima...